Overexpression of a RHAMM isoform (RHAMMΔ163) transforms fibroblasts but the mechanisms underlying this oncogenic function are not well understood. RHAMMΔ163 binds to the mitotic spindle and centrosomes via a C-terminal leucine zipper; these interactions are predicted to regulate genomic stability and cell polarity and proposed to account for the oncogenic function of RHAMMΔ163. We hypothesized that RHAMM leucine zipper maintains mitotic spindle integrity and impacts directional cell migration through its interactions with microtubule and centrosome structures. The consequences of a mutated leucine zipper on cell division, cell motility, and tumorigenesis were assessed. Although mutant RHAMMΔ163 promoted polycentrosomy, it did not alter cel...
The 5-year survival for localized rhabdomyosarcoma is over 70%, but only 30% for patients presenting...
PhDThe centrosome is the main microtubule-organising centre in animal cells; important to assemble ...
Expression of the hyaluronan-mediated motility receptor (RHAMM, CD168) predicts adverse clinicopatho...
An oncogenic form of RHAMM (receptor for hyaluronan-mediated motility, mouse, amino acids 163-794 te...
Cell division requires the assembly and organization of a microtubule-based mitotic spindle. Microtu...
In colorectal cancer (CRC), RHAMM is an independent adverse prognostic factor. The aim of the study ...
In colorectal cancer (CRC), RHAMM is an independent adverse prognostic factor. The aim of the study ...
AbstractOverexpression of the RHAMM gene by transfection into fibroblasts is transforming and causes...
Receptor for hyaluronan mediated motility (RHAMM, encoded by HMMR) may be a cell-surface receptor fo...
Receptor for hyaluronan mediated motility (RHAMM, encoded by HMMR) may be a cell-surface receptor fo...
ObjectiveThe study aims to explore the effects of receptor of hyaluronan mediated motility (RHAMM) o...
grantor: University of TorontoHyaluronan (Hyaluronic acid, hyaluronate, HA), a ubiquitous ...
In vitro studies have shown that inhibition of ribosomal biogenesis can activate p53 through ribosom...
A major component of the extracellular matrix is hyaluronan, a regulator of cell migration/survival ...
Background: The regulated assembly of microtubules is essential for bipolar spindle formation. Depen...
The 5-year survival for localized rhabdomyosarcoma is over 70%, but only 30% for patients presenting...
PhDThe centrosome is the main microtubule-organising centre in animal cells; important to assemble ...
Expression of the hyaluronan-mediated motility receptor (RHAMM, CD168) predicts adverse clinicopatho...
An oncogenic form of RHAMM (receptor for hyaluronan-mediated motility, mouse, amino acids 163-794 te...
Cell division requires the assembly and organization of a microtubule-based mitotic spindle. Microtu...
In colorectal cancer (CRC), RHAMM is an independent adverse prognostic factor. The aim of the study ...
In colorectal cancer (CRC), RHAMM is an independent adverse prognostic factor. The aim of the study ...
AbstractOverexpression of the RHAMM gene by transfection into fibroblasts is transforming and causes...
Receptor for hyaluronan mediated motility (RHAMM, encoded by HMMR) may be a cell-surface receptor fo...
Receptor for hyaluronan mediated motility (RHAMM, encoded by HMMR) may be a cell-surface receptor fo...
ObjectiveThe study aims to explore the effects of receptor of hyaluronan mediated motility (RHAMM) o...
grantor: University of TorontoHyaluronan (Hyaluronic acid, hyaluronate, HA), a ubiquitous ...
In vitro studies have shown that inhibition of ribosomal biogenesis can activate p53 through ribosom...
A major component of the extracellular matrix is hyaluronan, a regulator of cell migration/survival ...
Background: The regulated assembly of microtubules is essential for bipolar spindle formation. Depen...
The 5-year survival for localized rhabdomyosarcoma is over 70%, but only 30% for patients presenting...
PhDThe centrosome is the main microtubule-organising centre in animal cells; important to assemble ...
Expression of the hyaluronan-mediated motility receptor (RHAMM, CD168) predicts adverse clinicopatho...